$MRK Company News Three investments to own and
Post# of 94143
Posted On: 01/13/2015 11:02:50 AM
$MRK Company News
Three investments to own and three to 6:00 a.m. Today - Howard Gold
Bristol-Myers Squibb jumps on Opdivo cancer drug test 8:17 a.m. Jan. 12, 2015 - Angela Chen
Here are the best-performing stocks so far in 2015 11:47 a.m. Jan. 9, 2015 - Philip van Doorn
Ebola vaccines ready for West Africa tests: WHO 11:11 a.m. Jan. 9, 2015 - MarketWatch.com
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
FDA approves Bristol-Myers’s skin cancer treatment Opdivo 6:09 p.m. Dec. 22, 2014 - Ron Winslow
Nike slips after hours as orders fail to impress 6:38 p.m. Dec. 18, 2014 - MarketWatch
Merck acquires OncoEthix for up to $375 million 8:41 a.m. Dec. 18, 2014 - Angela Chen
From China to the U.S., a surreal week in business news 9:28 a.m. Dec. 12, 2014 - Marek Fuchs
Human trial of experimental Merck Ebola vaccine is suspended 2:17 p.m. Dec. 11, 2014 - Jeanne Whalen
Restoration Hardware shares jump on earnings beat 6:46 p.m. Dec. 10, 2014 - MarketWatch
Merck drug shrank tumors in some breast cancer patients in trial 8:57 a.m. Dec. 10, 2014 - Peter Loftus
Here are today’s biggest S&P 500 losers ... and five winners 12:51 p.m. Dec. 9, 2014 - Philip van Doorn
H&R Block shares fall on quarterly miss 6:41 p.m. Dec. 8, 2014 - Sue Chang
The S&P 500 recorded its biggest drop in nearly 7 weeks 4:33 p.m. Dec. 8, 2014 - Sara Sjolin
Russell 2000 rattles cage on major resistance 11:15 a.m. Dec. 8, 2014 - Michael Ashbaugh
Dow 18,000 beckons, but a bottom in oil prices does not 7:42 a.m. Dec. 8, 2014 - Shawn Langlois
Newscast: Oil prices plunge 7:38 a.m. Dec. 8, 2014 - MarketWatch
Merck to buy Cubist Pharmaceuticals for $8.4 billion 7:26 a.m. Dec. 8, 2014 - Peter Loftus
Merck to buy Cubist Pharmaceuticals in $9.5 billion deal 7:13 a.m. Dec. 8, 2014 - Tomi Kilgore
Lilly to Collaborate on Cancer Drug Trials 8:52 a.m. Today - The Wall Street Journal Interactive Edition
Lilly and Merck team up in cancer trials 8:44 a.m. Today - Seeking Alpha
Agenus Soars on Immuno-Oncology Agreement with Incyte - Analyst Blog 6:45 p.m. Jan. 12, 2015 - Zacks.com
Bristol’s Lung Cancer Drug Aces Trial, Cheers Bulls 3:13 p.m. Jan. 12, 2015 - Barrons.com
Bristol-Myers Hits 14-Year High On Cancer Drug Trial 1:25 p.m. Jan. 12, 2015 - Investors Business Daily
I'm Expecting Some Very Positive News Flow From Gilead 11:55 a.m. Jan. 12, 2015 - Seeking Alpha
Dow Jones (DJIA) Today: Merck (MRK) Leads The Day Higher, Chevron (CVX) Lags 10:00 a.m. Jan. 12, 2015 - TheStreet.com
Bristol-Myers’s Lung Cancer Drug Shows Success 9:32 a.m. Jan. 12, 2015 - The Wall Street Journal Interactive Edition
Merck to Continue Focus on Cancer Drug Keytruda 8:02 a.m. Jan. 12, 2015 - The Wall Street Journal Interactive Edition
5 Biotech Stocks With Explosive Drug Pipelines 8:01 a.m. Jan. 12, 2015 - InvestorPlace.com
Merck (MRK) Stock Higher Today as It Speeds Plans to Submit New Drugs 7:52 a.m. Jan. 12, 2015 - TheStreet.com
Merck accelerates regulatory submission plans in cancer and hepatitis 7:13 a.m. Jan. 12, 2015 - Seeking Alpha
Bristol-Myers Checkpoint Inhibitor Prolongs Lung Cancer Patient Survival 7:07 a.m. Jan. 12, 2015 - TheStreet.com
January 12 Premarket Briefing: 10 Things You Should Know 7:03 a.m. Jan. 12, 2015 - TheStreet.com
Merck & Co., Inc. (MRK): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 12, 2015 - Zacks.com
Merck Accelerates Drug-Submission Plans 11:04 p.m. Jan. 11, 2015 - The Wall Street Journal Interactive Edition
Bristol-Myers stops cancer trial early after Opdivo meets efficacy endpoint 10:29 p.m. Jan. 11, 2015 - Seeking Alpha
Ebola Vaccines Ready for West Africa Tests This Month, Says WHO 11:05 a.m. Jan. 9, 2015 - The Wall Street Journal Interactive Edition
The Bullish and Bearish Case for Pfizer in 2015 10:37 a.m. Jan. 9, 2015 - 247WallSt.com
Hall of Fame/ Hall of Shame: The Best and Worst Recommendations of 2014 9:25 a.m. Jan. 9, 2015 - GuruFocus.com
Vista Partners Initiates Coverage on OncoSec Medical (Ticker: ONCS); Price Target $1.20 9:02 a.m. Today - Marketwired
Lilly, Merck Enter Collaboration Agreement to Research Immuno-Oncology Combination Regimens in Multiple Types of Cancer 8:01 a.m. Today - BusinessWire - BZX
Moderna Announces License and Collaboration Agreement with Merck to Develop Messenger RNA-based Antiviral Vaccines and Passive Immunity Therapies 8:00 a.m. Today - PR Newswire - PRF
Neviah Genomics Achieves Key Development Milestone for PropheTox™ Bioassay for Early Prediction of Drug-Induced Liver Toxicity and Secures Additional Financing 7:00 a.m. Jan. 12, 2015 - BusinessWire - BZX
Adimab Announces New Partnerships with Acceleron, Oncothyreon, Surface Oncology and Potenza 9:45 a.m. Jan. 9, 2015 - BusinessWire - BZX
Beverage Industry Exec Ken Sadowsky Joins Theocorp Advisory Board 8:30 a.m. Jan. 9, 2015 - PR Newswire - PRF
Merck to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Jan. 9, 2015 - BusinessWire - BZX
Protagen AG Appoints Bernhard Kirschbaum as New Board Member 10:00 a.m. Jan. 8, 2015 - BusinessWire - BZX
Jounce Therapeutics Appoints Deborah Law, D.Phil., to Chief Scientific Officer 9:01 a.m. Jan. 8, 2015 - BusinessWire - BZX
Global Needle-free Drug Delivery Technologies market 2015-2019 2:58 p.m. Jan. 7, 2015 - PR Newswire - PRF
Global Psoriasis Therapeutics Market 2015-2019 2:12 p.m. Jan. 7, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
HMR Weight Management Services Named No. 2 Best Weight-Loss Diet in U.S. News & World Report's Best Diets of 2015 9:15 a.m. Jan. 6, 2015 - PR Newswire - PRF
Scaling New Heights: Complimentary Research on Stereotaxis, Kite Pharma, ISIS Pharma, Merck and General Motors 8:50 a.m. Jan. 6, 2015 - PR Newswire - PRF
Theralase Anti-Cancer Technology Picks Up Steam 7:00 a.m. Jan. 6, 2015 - ACCESSWIRE
REPEAT - EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:02 a.m. Jan. 5, 2015 - Marketwired
Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4 8:00 a.m. Jan. 5, 2015 - BusinessWire - BZX
EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:01 a.m. Dec. 29, 2014 - Marketwired
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 202 7:08 a.m. Dec. 23, 2014 - PR Newswire - PRF
Three investments to own and three to 6:00 a.m. Today - Howard Gold
Bristol-Myers Squibb jumps on Opdivo cancer drug test 8:17 a.m. Jan. 12, 2015 - Angela Chen
Here are the best-performing stocks so far in 2015 11:47 a.m. Jan. 9, 2015 - Philip van Doorn
Ebola vaccines ready for West Africa tests: WHO 11:11 a.m. Jan. 9, 2015 - MarketWatch.com
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
FDA approves Bristol-Myers’s skin cancer treatment Opdivo 6:09 p.m. Dec. 22, 2014 - Ron Winslow
Nike slips after hours as orders fail to impress 6:38 p.m. Dec. 18, 2014 - MarketWatch
Merck acquires OncoEthix for up to $375 million 8:41 a.m. Dec. 18, 2014 - Angela Chen
From China to the U.S., a surreal week in business news 9:28 a.m. Dec. 12, 2014 - Marek Fuchs
Human trial of experimental Merck Ebola vaccine is suspended 2:17 p.m. Dec. 11, 2014 - Jeanne Whalen
Restoration Hardware shares jump on earnings beat 6:46 p.m. Dec. 10, 2014 - MarketWatch
Merck drug shrank tumors in some breast cancer patients in trial 8:57 a.m. Dec. 10, 2014 - Peter Loftus
Here are today’s biggest S&P 500 losers ... and five winners 12:51 p.m. Dec. 9, 2014 - Philip van Doorn
H&R Block shares fall on quarterly miss 6:41 p.m. Dec. 8, 2014 - Sue Chang
The S&P 500 recorded its biggest drop in nearly 7 weeks 4:33 p.m. Dec. 8, 2014 - Sara Sjolin
Russell 2000 rattles cage on major resistance 11:15 a.m. Dec. 8, 2014 - Michael Ashbaugh
Dow 18,000 beckons, but a bottom in oil prices does not 7:42 a.m. Dec. 8, 2014 - Shawn Langlois
Newscast: Oil prices plunge 7:38 a.m. Dec. 8, 2014 - MarketWatch
Merck to buy Cubist Pharmaceuticals for $8.4 billion 7:26 a.m. Dec. 8, 2014 - Peter Loftus
Merck to buy Cubist Pharmaceuticals in $9.5 billion deal 7:13 a.m. Dec. 8, 2014 - Tomi Kilgore
Lilly to Collaborate on Cancer Drug Trials 8:52 a.m. Today - The Wall Street Journal Interactive Edition
Lilly and Merck team up in cancer trials 8:44 a.m. Today - Seeking Alpha
Agenus Soars on Immuno-Oncology Agreement with Incyte - Analyst Blog 6:45 p.m. Jan. 12, 2015 - Zacks.com
Bristol’s Lung Cancer Drug Aces Trial, Cheers Bulls 3:13 p.m. Jan. 12, 2015 - Barrons.com
Bristol-Myers Hits 14-Year High On Cancer Drug Trial 1:25 p.m. Jan. 12, 2015 - Investors Business Daily
I'm Expecting Some Very Positive News Flow From Gilead 11:55 a.m. Jan. 12, 2015 - Seeking Alpha
Dow Jones (DJIA) Today: Merck (MRK) Leads The Day Higher, Chevron (CVX) Lags 10:00 a.m. Jan. 12, 2015 - TheStreet.com
Bristol-Myers’s Lung Cancer Drug Shows Success 9:32 a.m. Jan. 12, 2015 - The Wall Street Journal Interactive Edition
Merck to Continue Focus on Cancer Drug Keytruda 8:02 a.m. Jan. 12, 2015 - The Wall Street Journal Interactive Edition
5 Biotech Stocks With Explosive Drug Pipelines 8:01 a.m. Jan. 12, 2015 - InvestorPlace.com
Merck (MRK) Stock Higher Today as It Speeds Plans to Submit New Drugs 7:52 a.m. Jan. 12, 2015 - TheStreet.com
Merck accelerates regulatory submission plans in cancer and hepatitis 7:13 a.m. Jan. 12, 2015 - Seeking Alpha
Bristol-Myers Checkpoint Inhibitor Prolongs Lung Cancer Patient Survival 7:07 a.m. Jan. 12, 2015 - TheStreet.com
January 12 Premarket Briefing: 10 Things You Should Know 7:03 a.m. Jan. 12, 2015 - TheStreet.com
Merck & Co., Inc. (MRK): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 12, 2015 - Zacks.com
Merck Accelerates Drug-Submission Plans 11:04 p.m. Jan. 11, 2015 - The Wall Street Journal Interactive Edition
Bristol-Myers stops cancer trial early after Opdivo meets efficacy endpoint 10:29 p.m. Jan. 11, 2015 - Seeking Alpha
Ebola Vaccines Ready for West Africa Tests This Month, Says WHO 11:05 a.m. Jan. 9, 2015 - The Wall Street Journal Interactive Edition
The Bullish and Bearish Case for Pfizer in 2015 10:37 a.m. Jan. 9, 2015 - 247WallSt.com
Hall of Fame/ Hall of Shame: The Best and Worst Recommendations of 2014 9:25 a.m. Jan. 9, 2015 - GuruFocus.com
Vista Partners Initiates Coverage on OncoSec Medical (Ticker: ONCS); Price Target $1.20 9:02 a.m. Today - Marketwired
Lilly, Merck Enter Collaboration Agreement to Research Immuno-Oncology Combination Regimens in Multiple Types of Cancer 8:01 a.m. Today - BusinessWire - BZX
Moderna Announces License and Collaboration Agreement with Merck to Develop Messenger RNA-based Antiviral Vaccines and Passive Immunity Therapies 8:00 a.m. Today - PR Newswire - PRF
Neviah Genomics Achieves Key Development Milestone for PropheTox™ Bioassay for Early Prediction of Drug-Induced Liver Toxicity and Secures Additional Financing 7:00 a.m. Jan. 12, 2015 - BusinessWire - BZX
Adimab Announces New Partnerships with Acceleron, Oncothyreon, Surface Oncology and Potenza 9:45 a.m. Jan. 9, 2015 - BusinessWire - BZX
Beverage Industry Exec Ken Sadowsky Joins Theocorp Advisory Board 8:30 a.m. Jan. 9, 2015 - PR Newswire - PRF
Merck to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Jan. 9, 2015 - BusinessWire - BZX
Protagen AG Appoints Bernhard Kirschbaum as New Board Member 10:00 a.m. Jan. 8, 2015 - BusinessWire - BZX
Jounce Therapeutics Appoints Deborah Law, D.Phil., to Chief Scientific Officer 9:01 a.m. Jan. 8, 2015 - BusinessWire - BZX
Global Needle-free Drug Delivery Technologies market 2015-2019 2:58 p.m. Jan. 7, 2015 - PR Newswire - PRF
Global Psoriasis Therapeutics Market 2015-2019 2:12 p.m. Jan. 7, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
HMR Weight Management Services Named No. 2 Best Weight-Loss Diet in U.S. News & World Report's Best Diets of 2015 9:15 a.m. Jan. 6, 2015 - PR Newswire - PRF
Scaling New Heights: Complimentary Research on Stereotaxis, Kite Pharma, ISIS Pharma, Merck and General Motors 8:50 a.m. Jan. 6, 2015 - PR Newswire - PRF
Theralase Anti-Cancer Technology Picks Up Steam 7:00 a.m. Jan. 6, 2015 - ACCESSWIRE
REPEAT - EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:02 a.m. Jan. 5, 2015 - Marketwired
Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4 8:00 a.m. Jan. 5, 2015 - BusinessWire - BZX
EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:01 a.m. Dec. 29, 2014 - Marketwired
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 202 7:08 a.m. Dec. 23, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼